Skip to main content
. 2020 Feb 3;11(5):862–868. doi: 10.1021/acsmedchemlett.9b00654

Table 1. Inhibitory Activity of Derivatives 16 on PARP1/2 and TNKS1/2.

  IC50 (nM)a
Compd PARP-1 PARP-2 TNKS1 TNKS2
MC2050 9.3 ± 0.09 549 ± 12 218 ± 8 193 ± 7
1 2040 ± 61 340 ± 11 673 ± 28 588 ± 19
2 1480 ± 58 370 ± 8 37.4 ± 0.4 11.7 ± 0.3
3 1280 ± 49 347 ± 13 552 ± 18 103 ± 4
4 356 ± 14 963 ± 39 398 ± 14 318 ± 13
5 89.6 ± 2.2 37.8 ± 1.1 6.1 ± 0.07 0.3 ± 0.005
6 26% inhib. (@200 μM) 132000 ± 987 NIb (@200 μM) NI (@200 μM)
PJ34 9.1 ± 0.09 14.7 ± 0.4 39.2 ± 0.9 52.7 ± 1.2
IWR-1 NI (@200 μM) NI (@200 μM) 303 ± 9 29.2 ± 0.8
a

Values are means ± SD determined from at least two independent experiments, each one done in triplicate.

b

NI, no inhibition.